[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Bio-based Material Quarterly Newsletter Q3 2022

September 2022 | 27 pages | ID: B81BD4848D74EN
Guangzhou CCM Information Science & Technology Co., Ltd. (CCM)

US$ 3,564.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Welcome to the Bio-based Material Quarterly Newsletter Q3 2022.

Policy

China's MIIT and other departments jointly issued an implementation plan for the high-quality development for raw materials industry, highlighting bio-based materials in Sept.

Market dynamics & company performance

In H1 2022, Kingfa reported tumbling net profit, in comparison with many other players like Jindan Technology, Zhongke Biotech, Cathay Biotech, COFCO Biotech which have performed well and continued to make progress in their biodegradable material projects. Hisun Biomaterials went public on Shanghai's STAR Market in Aug.

Multiply PLA-related projects are brought up in China, including BBCA Biochemical's 5,000 t/a D-lactic acid and 3,000 t/a PLA industrialisation projects, Zhongke Baichuang Environmental Biotechnology (Guantao) Co., Ltd.'s 300,000 t/a PLA project, Huakang Pharma's 2 million t/a corn processing project (including products of LA and PLA), along with some seeing further development, i.e. Jiangxi Keyuan's and Langjing New Material's PLA projects.

There are updates on other bio-based material projects, including the bio-based new material projects in Zhangjiagang Jiutai, Jinzhu New Material and Anhui Huizhu, the fibre composite new material project in Yibin Grace Hygienic Materials Technology Co., Ltd., the starch-based biodegradable material project in Zhongshan Co-polymer. Two new bio-based fibre projects were firstly unveiled by Youxian Technology (Dandong) Co., Ltd. and Anhui HengRun Chemical Fiber Co., Ltd.; Weigou Workshop plans to build China's biggest 30,000 t/a PHA production base; Huaheng Biotech pushes SA and PDO industrialisation; CellUranics raised tens of millions RMB in angel financing; GS Biotech kicked off construction of bio-based degradable materials (HMF, FDCA, and more) base project; Puyang Baiaomaisi announced completion of its 50 t/a FDCA pilot-scale equipment installation.

Price

In the third quarter of 2022, PLA prices rose slightly but sustaining at an overall low level. PHA prices were levelling off.
Headline
Editor's Note
Governmental Direction
China releases implementation plan for high-quality raw material industry development
Market Analysis
Jindan Technology and Kingfa release performance reports for H1
Zhongke Biotech & Cathay Biotech: Developments in LCDA and PA projects
Hisun Biomaterials makes debut on Shanghai's STAR Market
COFCO Biotech progresses biodegradable materials projects
Company Dynamics
Advance of China's PLA projects
New bio-based fibre / fibre composite projects in China
BBCA Biochemical drafts 5,000 t/a D-lactic acid and 3,000 t/a PLA industrialisation projects
Zhangjiagang Jiutai to produce PTT new bio-based material
Publicity of bio-based projects of Jinzhu New Material and Anhui Huizhu
Price Update
News in Brief
Angel Yeast and Weigou Workshop to co-found China's biggest 30,000 t/a PHA production base
Huakang Pharma planning 2 million t/a corn processing project including LA and PLA
CellUranics closes tens of millions RMB of angel financing
GS Biotech's bio-based degradable materials base project kicks start construction
Huaheng Biotech pushes SA and PDO industrialisation
Puyang Baiaomaisi initiates operation of 50 t/a FDCA pilot-scale equipment
Zhongshan Co-polymer approved for starch-based biodegradable material project


More Publications